These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29255995)

  • 41. Prevalence of bone fractures among children and adolescents with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.
    Seens H; Modarresi S; MacDermid JC; Walton DM; Grewal R
    BMC Pediatr; 2021 Aug; 21(1):354. PubMed ID: 34412606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studies.
    Catalá-López F; Hutton B; Page MJ; Ridao M; Driver JA; Alonso-Arroyo A; Forés-Martos J; Macías Saint-Gerons D; Vieta E; Valencia A; Tabarés-Seisdedos R
    Syst Rev; 2017 Sep; 6(1):189. PubMed ID: 28915839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors Associated With Children Diagnosed With Attention-Deficit/Hyperactivity Disorder and 30-Day Follow-up Care With Practitioners Among Medicaid Recipients in Georgia.
    Yin H; Ibe B; Parr TL; Csukas S; Jones BL; Thompson S
    Qual Manag Health Care; 2022 Jul-Sep 01; 31(3):154-159. PubMed ID: 34571512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between attention deficit hyperactivity disorder and asthma: a systematic review and meta-analysis and a Swedish population-based study.
    Cortese S; Sun S; Zhang J; Sharma E; Chang Z; Kuja-Halkola R; Almqvist C; Larsson H; Faraone SV
    Lancet Psychiatry; 2018 Sep; 5(9):717-726. PubMed ID: 30054261
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Considerations in the Care of Athletes With Attention Deficit Hyperactivity Disorder.
    Pujalte GGA; Maynard JR; Thurston MJ; Taylor WC; Chauhan M
    Clin J Sport Med; 2019 May; 29(3):245-256. PubMed ID: 29189334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing undertreatment and overtreatment/misuse of ADHD medications in children and adolescents across continents: A systematic review and meta-analysis.
    Massuti R; Moreira-Maia CR; Campani F; Sônego M; Amaro J; Akutagava-Martins GC; Tessari L; Polanczyk GV; Cortese S; Rohde LA
    Neurosci Biobehav Rev; 2021 Sep; 128():64-73. PubMed ID: 34089763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between sleep duration and attention-deficit hyperactivity disorder: A systematic review and meta-analysis of observational studies
    Lee SH; Kim HB; Lee KW
    J Affect Disord; 2019 Sep; 256():62-69. PubMed ID: 31158717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of baseline and post-concussion ImPACT test scores in young athletes with stimulant-treated and untreated ADHD.
    Gardner RM; Yengo-Kahn A; Bonfield CM; Solomon GS
    Phys Sportsmed; 2017 Feb; 45(1):1-10. PubMed ID: 27736285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study.
    Vasiliadis HM; Lunghi C; Rahme E; Rochette L; Gignac M; Massamba V; Diallo FB; Fansi A; Cortese S; Lesage A
    Transl Psychiatry; 2024 Feb; 14(1):128. PubMed ID: 38418443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of stimulant and non-stimulant drug treatment on driving performance in patients with attention deficit hyperactivity disorder: a systematic review.
    Gobbo MA; Louzã MR
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1425-43. PubMed ID: 25044052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
    Fredriksen M; Dahl AA; Martinsen EW; Klungsøyr O; Haavik J; Peleikis DE
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1873-84. PubMed ID: 25453480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between medication prescription for atopic diseases and attention-deficit/hyperactivity disorder.
    van der Schans J; Pleiter JC; de Vries TW; Schuiling-Veninga CC; Bos JH; Hoekstra PJ; Hak E
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):186-91. PubMed ID: 27315741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis.
    Coghill DR; Seth S; Pedroso S; Usala T; Currie J; Gagliano A
    Biol Psychiatry; 2014 Oct; 76(8):603-15. PubMed ID: 24231201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
    McCabe SE; Dickinson K; West BT; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Managing attention deficit hyperactivity disorder in adults using illicit psychostimulants: A systematic review.
    Cook J; Lloyd-Jones M; Arunogiri S; Ogden E; Bonomo Y
    Aust N Z J Psychiatry; 2017 Sep; 51(9):876-885. PubMed ID: 28639480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study.
    Rose SR; Reeves G; Gut R; Germak J
    J Pediatr; 2015 Dec; 167(6):1389-96. PubMed ID: 26394822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
    Rohatgi RK; Bos JM; Ackerman MJ
    Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of poisoning in children and adolescents with ADHD: a systematic review and meta-analysis.
    Ruiz-Goikoetxea M; Cortese S; Magallón S; Aznárez-Sanado M; Álvarez Zallo N; Luis EO; de Castro-Manglano P; Soutullo C; Arrondo G
    Sci Rep; 2018 May; 8(1):7584. PubMed ID: 29765117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.